Affiliations of authors: Arizona Cancer Center (ETJ, MEM, DSA), College of Public Health (ETJ, MEM, DSA), Nutritional Sciences Interdisciplinary Program (MEM, DSA), and Department of Medicine (DSA), University of Arizona, Tucson.
Correspondence to: Elizabeth T. Jacobs, PhD, College of Public Health, Arizona Cancer Center, University of Arizona, P.O. Box 245024, Tucson, AZ 857245024 (e-mail: jacobse{at}u.arizona.edu)
In this issue of the Journal, Grau et al. (1) present the results of a study investigating whether calcium supplementation, vitamin D, and vitamin D receptor (VDR) polymorphismsalone or in combinationaffect the risk of colorectal adenoma recurrence. This study provides the framework for consideration of issues related to the reported results, as well as to future cancer epidemiologic studies. These issues include 1) the need for further examination of the protective benefits of calcium and vitamin D on colorectal cancer and its precursors, 2) the necessity of and potential approaches for epidemiologic studies that address both genetic and environmental factors, and 3) the public health implications of a protective effect of calcium and vitamin D on the risk of colorectal neoplasia.
In Grau et al. (1), subjects were participants from the Calcium Polyp Prevention Study (2), a Phase III trial in which a statistically significantly reduced risk for adenoma recurrence was observed with supplementation of 1200 mg/day of calcium over 4 years as compared with placebo. Elaborating on these findings, Grau et al. observed that higher serum 25-hydroxyvitamin D (25-OHD) levels were associated with a protective effect on colorectal adenoma recurrence in the calcium-supplemented group but not in the placebo arm. 25-OHD is the precursor to 1,25-dihydroxyvitamin D (1,25-(OH)2D3), a hormone that has been demonstrated to have anti-proliferative and pro-differentiating effects in colon cancer cell lines (35). The mechanism by which the precursor 25-OHD might have protective effects among individuals supplemented with calcium is unclear, because calcium would ultimately tend to decrease the production of 1,25-(OH)2D3. Perhaps the presence of adequate calcium allows for the diversion of 1,25-(OH)2D3 to antineoplastic activities. Despite this uncertainty, the work of Grau et al. adds to the evidence from other published reports (68), which have demonstrated repeatedly that calcium and vitamin D modify each others effects. These observations, as well as the intricate biologic association between calcium and vitamin D, highlight the importance of including both nutrients as exposure variables in future epidemiologic studies. Without consideration of these nutrients together, it will be difficult to elucidate the mechanism of effect or to make recommendations regarding the appropriate intake of either.
Another aspect of interest in the current work was the assessment of the association between TaqI or FokI VDR polymorphisms and risk of adenoma recurrence, either independently or in conjunction with vitamin D or calcium. Functional studies have revealed that specific polymorphic alleles may confer greater transcriptional activity than other alleles (9). Some epidemiologic studies (10,11) have reported associations between these polymorphisms and risk of colorectal adenoma and/or cancer. However, the current work revealed no association of either polymorphism with adenoma recurrence, results that are in agreement with those of Peters et al. (6). Discrepancies among association studies of polymorphic variants have been a topic of great recent interest. Possible explanations for the differences include the composition of the study populations, undetected geneenvironment interactions, or laboratory error. Furthermore, studies of adenoma recurrence have their own limitations that need to be taken into account (12), including assessment of surrogate endpoints rather than cancer, short length of follow-up, and the inclusion of only individuals with a history of adenomatous polyps. Thus, clarification of associations between calcium, vitamin D, and VDR variants in additional studies with adequate statistical power is warranted.
The observation of a protective effect of calcium and vitamin D on colorectal adenoma recurrence in the current work leads to the question of how to apply this information to the prevention of colorectal cancer. The evidence presented in this and other articles indicates that calcium and vitamin D may be important at several stages of carcinogenesis, presenting an interesting conundrum regarding recommended intake. Because milk is one of the primary sources of both calcium and vitamin D, should increased consumption of dairy products be advised? The possibility of a positive association between prostate cancer risk and consumption of dairy products (13), as well as the problem of lactose intolerance, militates against this approach. An alternative approach, suggested by Tangpricha et al. (14), involves vitamin D fortification of orange juice, which often has calcium added; the use of multivitamins containing vitamin D may also be an option. Although a recommendation for brief, daily sun exposure may be in order (15), such a recommendation clearly comes with its own set of challenges with regard to optimal dose and duration because the ability to endogenously synthesize vitamin D will vary by age, latitude, skin pigmentation, and use of sunscreen (16). It will be difficult to make recommendations until more precise information is available regarding the interaction of these nutrients with susceptibility genes, other nutrients, and the environment. Moreover, although an association of calcium with reduced risk of colorectal neoplasia has been observed in both observational and intervention studies, it must be emphasized that the effect is modest. Therefore, it may currently be more beneficial to focus colorectal cancer prevention efforts on those factors for which higher risk reduction can be achieved, such as increased physical activity, higher intake of fruits and vegetables, and lower intake of red meat (17).
The article by Grau et al. also serves as a reminder of the gargantuan research task that awaits cancer epidemiologists. The identification and analysis of the vast number of polymorphic variants, nutrients, and environmental exposures that influence the risk of cancer, the interactions among these factors, and their multiple outcomes leave ample room for several different approaches. Rapidly developing technology allows for extremely efficient identification of large numbers of genes, mutations, proteins, and polymorphic variants that may occur exclusively in cancer. Application of epidemiologic and statistical methodology is required to ensure that the data generated have meaningful biologic associations. For this reason, there remains a strong need for smaller, well-designed studies centered around candidate genes and specific carcinogenic pathways. These smaller studies will serve to further explore potential mechanistic pathways as well as to replicate larger studies.
In summary, the article by Grau et al. serves as a catalyst for further exploration of the mechanisms by which calcium and vitamin D may interact to prevent colorectal neoplasia. Moreover, the work serves as a compelling reminder of the need for large association studies that include consideration of both genetic and environmental components, as well as the need for functional studies of candidate genes. Both approaches are necessary to identify risk and susceptibility factors for carcinogenesis.
REFERENCES
1 Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:176571.
2 Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999;340:1017.
3 Giuliano AR, Franceschi RT, Wood RJ. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 1991;285:2619.[ISI][Medline]
4 Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MA, Puig I, Baulida J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001;154:36987.
5 Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 1993;53: 37128.[Abstract]
6 Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas, Rothman N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2001;10:126774.
7 Zheng W, Anderson KE, Kushi LH, Sellers TA, Greenstein J, Hong CP, et al. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:2215.[Abstract]
8 Levine AJ, Harper JM, Ervin CM, Chen YH, Harmon E, Xue S, et al. Serum 25-hydroxyvitamin D, dietary calcium intake, and distal colorectal adenoma risk. Nutr Cancer 2001;39:3541.[ISI][Medline]
9 Jurutka PW, Remus LS, Whitfield GK, Thompson PP, Hsieh JC, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000;14:40120.
10 Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 2001;12:60714.[CrossRef][ISI][Medline]
11 Slattery ML, Yakumo K, Hoffman M, Neuhausen S. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control 2001;12:35964.[CrossRef][ISI][Medline]
12 Martinez ME. Hormone replacement therapy and adenoma recurrence: implications for its role in colorectal cancer risk. J Natl Cancer Inst 2001;93:17645.
13 Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 2001;23:8792.[ISI][Medline]
14 Tangpricha V, Koutkia P, Rieke SM, Chen TC, Perez AA, Holick MF. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 2003;77:147883.
15 Ley SJ, Horwath CC, Stewart JM. Attention is needed to the high prevalence of vitamin D deficiency in our older population. N Z Med J 1999;112:4712.[ISI][Medline]
16 Holick MF. Vitamin D: physiology, molecular biology, and clinical applications. Totowa (NJ): Humana Press; 1999.
17 Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2002;52:92119.
This article has been cited by other articles in HighWire Press-hosted journals:
Correspondence about this Article
![]() |
||||
|
Oxford University Press Privacy Policy and Legal Statement |